IFC mulls up to $200m loan for China’s COVID-19 vaccine maker Fosun Pharma

Premium

The International Finance Corp (IFC), the private sector arm of the World Bank, is considering offering a straight senior loan of up to $200 million to Shanghai Fosun Pharmaceutical to support the Chinese firm’s production of medical products including the COVID-19 vaccine, the IFC disclosed this week.

Go to Source